LDN Dermatology Webinar – Providers

Thank you for your interest in Low Dose Naltrexone & Dermatologic Conditions!

Naltrexone, a drug that has been FDA approved since 1984 for alcohol & narcotic dependence is being used successfully in small doses for a variety of dematological conditions such as:

  • Atopic Dermatitis
  • Psoriasis
  • Lichen Planopilaris
  • Hailey-Hailey Disease
  • Wound Healing

Register for the webinar on Thursday, August 26, 2021 at 5:30 p.m. below!